Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida-Reference-Cited by-同舟云学术

Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida

Published:2002-01-14 Issue:1 Volume:108 Page:1-6
ISSN:0148-7299
Container-title:American Journal of Medical Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Shaw Gary M.,Lammer Edward J.,Zhu Huiping,Baker Mei Wang,Neri Eric,Finnell Richard H.

Funder

Science to Achieve Results (STAR) Program, the U.S. Environmental Protection Agency

Cooperative Agreement Program Announcement 643, Centers of Excellence for Surveillance, Research, Service and Evaluation Aimed at Birth Defects, Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Genetics(clinical)

Reference36 articles.

1. Potocytosis: sequestration and transport of small molecules by caveolae;Anderson;Science,1992

2. Lack of association between mutations in the folate receptor-α gene and spina bifida;Barber;Am J Med Genet,1998

3. The role of folate transport and metabolism in neural tube defect risk;Barber;Mol Genet Metab,1999

4. A data-based approach to diet questionnaire design and testing;Block;Am J Epidemiol,1986

5. 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review;Botto;Am J Epidemiol,2000

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and Outcomes of Patients With Spina Bifida in Texas by Patient Age;Journal of Surgical Research;2024-08

2. Temporal trends in paediatric hydrocephalus – Rising prematurity and persistent ophthalmological challenges;Acta Paediatrica;2024-04-25

3. Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes;Biomedicines;2023-01-25

4. The Concept of Folic Acid in Health and Disease;Molecules;2021-06-18

5. The effects of drug transporters on the efficacy of methotrexate in the treatment of rheumatoid arthritis;Life Sciences;2021-03